Company intelligence / Profile preview

Ophthalmic Technologies

Canada

Ownership: Private
Development stage: Other

Overview

Ophthalmic Technologies, Inc. (OTI) was a Canadian private medical device company specializing in ophthalmology diagnostic imaging systems, notably the Spectral SLO OCT system. The company's lead technology was commercial and distributed globally. In late 2007, OTI was acquired by OPKO Health, which integrated its diagnostic imaging technology into its ophthalmic business strategy, aligning the platform with therapeutic development for eye diseases such as age-related macular degeneration.

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Medical Imaging

Beyond the preview

Go deeper on Ophthalmic Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ophthalmic Technologies.

Explore the full profile